3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Thoracic
2
Other hematologic neoplasm
2
Myeloid
2
Genitourinary
2
Gastrointestinal
2
Breast
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Lymphoid
1
Gynecologic
1
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
7
Uterine Cervical Dysplasia
4
Papillomavirus Infections
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Precancerous Conditions
2
HIV Infections
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thromboembolism
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Watchful Waiting
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled